Khurram Jamil, Chief Medical Officer at GALECTIN THERAPEUTICS INC (GALT), sold 69,002 shares at $4.20 ($266K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Open-market sale of $266k GALT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.20 | 13,055 | $55K | 20.6% |
| 2 | $4.20 | 13,055 | $55K | 20.6% |
| 3 | $3.65 | 21,446 | $78K | 29.4% |
| 4 | $3.65 | 21,446 | $78K | 29.4% |
| Total | $3.86 avg | 69,002 | $266K | 100% |
| Filing → |
| GALT | SELL | 2026-06-25 | $24K | — | Filing → |
| GALT | SELL | 2026-05-28 | $2K | — | Filing → |
| GALT | SELL | 2026-01-05 | $33K | — | Filing → |